Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma Interventions: Drug: Daratumumab; Drug: velcade; Drug: Lenalidomide; Drug: dexamethasone Sponsors: European Myeloma Network; Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials